BIOSENTINEL, LLC

Basic Information

510 Charmany Drive
Suite 259
Madison, WI, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 199748000
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. SBIR Phase II: De novo assays for detection of the proteolytic activity in botulinum neurotoxin-based pharmaceuticals

    Amount: $416,365.00

    This Small Business Innovation Research (SBIR) Phase II project proposes to complete development of a universal, in vitro assay for determining the enzymatic activity of botulinum neurotoxin (BoNT)-ba ...

    SBIR Phase II 2012 National Science Foundation
  2. A Cell-based Assay for Botulinum Neurotoxin Detection and Development

    Amount: $1,425,680.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) are the most toxic substances known to humans, causing respiratory failure. Because of their lethality and ease of production, the De ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Validation of a cell-based assay for BoNT/A detection against the mouse bioassay

    Amount: $212,310.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNT) are the most toxic substances known to humans, causing respiratory failure upon intoxication. Despite their lethality, BoNTs have clin ...

    SBIR Phase I 2011 Department of Health and Human Services
  4. SBIR Phase I:De novo assays for detection of the proteolytic activity in botulinum neurotoxin-based pharmaceuticals

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to develop a universal, in vitro assay for determining the enzymatic activity of botulinum neurotoxin (BoNT)-based pharmaceutica ...

    SBIR Phase I 2010 National Science Foundation
  5. A Cell-based Assay for Botulinum Neurotoxin Detection and Development

    Amount: $587,536.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNT) are the most toxic substances known to humans causing respiratory failure upon poisoning. BoNT's lethality and ease of production has ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government